HARP Harpoon Therapeutics Net earnings per share growth this year

HARP (Harpoon Therapeutics) - company brandmark

Year-over-year EPS dynamics visualize the expansion of the Harpoon Therapeutics (HARP) TriTAC cancer-fighting platform, with the metric holding around 92.50. The stability of the trend is bolstered by strict climate control during drug delivery and the neutral geopolitical status of the research. Support from the US pharmaceutical sector minimizes external risks, allowing investors to effectively filter out market noise through this indicator.

Harpoon Therapeutics, Inc. (HARP): Net earnings per share growth this year from 07/04/2022 to 03/16/2024

Analytical breakdowns and data insights for company Harpoon Therapeutics Corp (HARP)

- current quotes and average value forecast:
Summary company analysis:HARP (Harpoon Therapeutics)
Brand item of Harpoon Tx

Investors require objective performance markers to assess the fundamental value of Harpoon Therapeutics assets. This metric measures the annual dynamics of earnings per share, allowing them to filter out market noise and identify the actual growth rate of net yield. An analysis of the net income per share YoY change ratio confirms the business's resilience, underpinned by the protected TriTAC platform and the successful integration of R&D assets into the oncology sector.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year sonnetbio.com (SONN)|MAIA: Earnings per share trend in current year|Liminatus Pharma Inc. - Net earnings per share growth this year|LAVA Therapeutics N.V. (LVTX) - Earnings per share growth rate in current year|NXTC - Earnings per share growth in current year|LPTX: Earnings per share growth in current year|Intensity Therapeutics (INTS) - Earnings per share growth in current year|Earnings per share growth rate in current year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth in current year|Gritstone bio (GRTS) - Expected net earnings per share growth this year|Earnings growth in current year KA|Expected net earnings per share growth this year NexImmune Inc|Earnings per share growth in current year turnstonebio.com TSBX|Expected net earnings per share growth this year Vaccinex Inc (VCNX)